Takayo Ueno
Shinjuku, 1631334, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies.
Journal: Journal of personalized medicine
Published: January 26, 2022
Enhancing the Endocytosis of Phosphatidylserine-Containing Liposomes through Tim4 by Modulation of Membrane Fluidity.
Journal: Molecular pharmaceutics
Published: December 16, 2021
Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participants.
Journal: Scientific reports
Published: September 14, 2021
Population Pharmacokinetic Analysis of Daclatasvir, Asunaprevir, and Beclabuvir Combination in HCV-Infected Subjects.
Journal: Clinical pharmacology in drug development
Published: August 22, 2018
Safety Exposure-Response Analysis for Daclatasvir, Asunaprevir, and Beclabuvir Combinations in HCV-Infected Subjects.
Journal: Journal of clinical pharmacology
Published: August 09, 2018
Population Pharmacokinetic Analysis for Daclatasvir and Asunaprevir in Japanese Subjects With Chronic Hepatitis C Virus Infection.
Journal: Journal of clinical pharmacology
Published: January 23, 2018
Exposure-Response (Efficacy) Analysis of Daclatasvir and Asunaprevir in Japanese Patients With Hepatitis C Virus Infection.
Journal: Journal of clinical pharmacology
Published: January 18, 2018
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects.
Journal: British journal of clinical pharmacology
Published: May 28, 2017
Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection.
Journal: Infectious diseases and therapy
Published: February 15, 2017
Population Pharmacokinetic Analysis of Daclatasvir in Subjects with Chronic Hepatitis C Virus Infection.
Journal: Clinical pharmacokinetics
Published: January 10, 2017
Single- and multiple-ascending dose studies to evaluate the safety, tolerability, and pharmacokinetics of daclatasvir and asunaprevir in healthy male Japanese subjects.
Journal: International journal of clinical pharmacology and therapeutics
Published: March 06, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026